1
0
0
News
Art and Hollie's Notes From the AAN Meeting in ...
msnews.acceleratedcure.org
Pardo, Per Soelberg Sorensen, Bettina Stubinski. This was a presentation of the data that allowed Rebif to bring a new formulation on the ...
Study - Health, Medicine and Natural Healing RemedySpot.com
www.remedyspot.com
Original Text D Mikol MD a , Frederik Barkhof MD b, Chang PhD c, K Coyle MD d, R Jeffery MD e, R Schwid MD f, Bettina Stubinski MD g, ...
Telephone & Addresses
WhitePages: Bettina Stubinski | Whitepages
View phone, address history, email, public records for the 1 people named Bettina Stubinski. Whitepages is the most trusted directory.
Physicians & MDs
DEFINE_ME
www.thelancet.com
... Chris H Polman MD e, Prof Bernard MJ Uitdehaag MD e, Florence Casset-Semanaz MSc f, Brian Hennessy MSc f, Margaretha Stam Moraga MSc f, Sanda Rocak PhD f, Bettina Stubinski MD f
Network Profiles
LinkedIn: Bettina Stubinski | LinkedIn
Visualizza il profilo professionale di Bettina Stubinski su LinkedIn. LinkedIn è la rete professionale più grande al mondo utilizzata dai professionisti come ...
LinkedIn: Bettina Stubinski - Schweiz | LinkedIn
Sehen Sie sich das Karriere-Profil von Bettina Stubinski (Schweiz) auf LinkedIn an. LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und ...
LinkedIn: Bettina Stubinski - Schweiz | LinkedIn
Übersicht von Bettina Stubinski Empfehlungen 1 Person hat Bettina Stubinski empfohlen Kontakte 500+ Kontakte
Interests
40th Anniversary of the MIT Club of Switzerland
www.wherevent.com
On the occasion of the 40th anniversary of the MIT Club of Switzerland this year we cordially invite you to our special gala e...
Auris Medical Holding's (EARS) CEO Thomas Meyer on Q Results -...
seekingalpha.com
· With me are Thomas Meyer, Chairman and Chief Executive Officer; Sven Zimmermann, Chief Financial Officer; and Bettina Stubinski, Chief Medical Officer.
LandOfFree - Inventor - Bettina Stubinski
canadianpatents.landoffree.com
Check out Bettina Stubinski. Rate and share your experience with other people.
Lancet Neurology, The - Vol n° 1 - EM consulte
www.em-consulte.com
Le site de référence en informations médicales et paramédicales - EM|consulte
Business Profiles
Xing: Bettina Stubinski
Dr. / Biotech / Pharma Executive Consultant / San Francisco / Biotechnology, Board of Directors, Chief Medical Officer, … industry, Sailing licence
patentbuddy: Bettina Stubinski
BERLIN-CHEMIE AG, Berlin, DE
Education
Efficacy and safety of subcutaneous interferon beta-1a in...
journals.scholarsportal.info
Nicola De Stefano; Maria Pia Sormani; Bettina Stubinski; Gregg Blevins; Jelena S. Drulovic; Delphine Issard; Penko Shotekov; Claudio Gasperini ...
Books & Literature
authors:"Bettina Stubinski" - Search | Paperity
paperity.org
Paperity: the 1st multidisciplinary aggregator of Open Access journals & papers. Free fulltext PDF articles from hundreds of disciplines, all in one place
Scientific Publications
Moving toward earlier treatment of multiple sclerosis: Findings from...
www.sciencedirect.com
Bettina Stubinski was an employee of Merck Serono S.A.—Switzerland at the time of manuscript preparation. Ludwig Kappos has received institutional research support from Acorda, Actelion, Advancell, Allozyne, Barofold, Bayer, Bayhill, Biogen Idec, BioMarin, Boehringer Ingelheim, CSL Behring, Eli Lilly, Geneuro, ...
Publications
Patient subgroup analyses of the treatment effect of subcutaneous...
link.springer.com
(7); Bettina Stubinski · (7); Dominic L. Jack · (8); Ludwig Kappos · ...
Comparison of subcutaneous interferon beta-1a with glatiramer acetate...
www.wikidata.org
scientific article published on 11 September 2008
Miscellaneous
Bettina Stubinski | LinkedIn
www.linkedin.com
View Bettina Stubinski's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Bettina Stubinski discover ...
EP A2 - Stabilized brivudine topical formulations containing...
patents.google.com
There is disclosed the use of metal-oxides pigments as photodegradation stabilizers in topical compositions containing brivudine
CA A1 - Stabilized brivudine topical formulations containing...
patents.google.com
Applicant, Berlin-Chemie Ag, Ulrike Gehlert, Karsten Groger, Reinhard Schmitz, Karl-Heinz Schrader, Andreas Schrader, Marc Wihsmann, Carlo Alberto Maggi, Stefano Manzini, Bettina Stubinski, Menarini Ricerche S.P.A.. Export Citation, BiBTeX, EndNote, RefMan. Classifications (28), Legal Events (2).
Edited Transcript of EARS earnings conference call or presentation
finance.yahoo.com
With me are Thomas Meyer, Auris Medical's Chairman and Chief Executive Officer; Sven Zimmermann, Chief Financial Officer; and Bettina Stubinski, Chief Medical Officer. Earlier today, we issued a press release with our fourth-quarter and full-year results and a business update. The release is ...
Study To Evaluate The Immunogenicity And Safety Of r-hIFN Beta-1a...
www.clinicaltrials.gov
Name/Title: Bettina Stubinski/Senior Medical Director Organization: Merck Serono SA - Geneva phone: +
Clinical trial: A Study to Evaluate Rebif® New Formulation...
www.druglib.com
Official(s) and/or principal investigator(s): Bettina Stubinski,, MD, Study Director, Affiliation: Merck Serono International SA, an affiliate of Merck KGaA Darmstadt, Germany.
A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in...
clinicaltrials.gov
Bettina Stubinski, Medical Director, Merck Serono SA - Geneva an affiliate of Merck KGaA Darmstadt, Germany: ClinicalTrials.gov Identifier:
Oral Cladribine in Early Multiple Sclerosis (MS) - Full Text View -...
clinicaltrials.gov
Bettina Stubinski, MD: Merck Serono S.A., Geneva: More Information. No publications provided by EMD Serono Additional publications automatically indexed to this study ...
Auris Medical AG Announces Completion Of Interim Analysis In...
www.biospace.com
Auris Medical AG Announces Completion Of Interim Analysis In Post-Acute Tinnitus Stratum Of TACTT3 Trial With AM read this article along with other...
A Multicentre, Single Arm, Open-Label, Phase IIIB Study to Evaluate...
www.clinicalconnection.com
Clinical trials listings, notifications, and news.
Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis...
clinicaltrials.gov
Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis (RNF) This study has been completed Bettina Stubinski, MD: Merck Serono SA - Geneva:
Clinical trial: Oral Cladribine in Early Multiple Sclerosis (MS)
www.druglib.com
Condition(s) targeted: Multiple Sclerosis. Intervention: Cladribine (Drug); Cladribine (Drug); Placebo (Drug); Rebif® new formulation (RNF) (Drug). Phase: Phase 3. Status: Completed. Sponsored by: EMD Serono. Official(s) and/or principal investigator(s): Bettina Stubinski, MD, Study Director, Affiliation: Merck Serono S.A., ...
Patient subgroup analyses of the treatment effect of subcutaneous...
read.qxmd.com
Hennessy, Lorenz Lehr, Bettina Stubinski, Dominic L Jack, Ludwig Kappos.
Gregg Blevins
www.infona.pl
Nicola De Stefano, Maria Pia Sormani, Bettina Stubinski, Gregg Blevins, more · Journal of the Neurological Sciences 312 , 1-2 , The IMPROVE ...
[PDF] Efficacy of subcutaneous interferon β-1a on MRI outcomes in a...
www.semanticscholar.org
Lorenz Lehr,6 Bettina Stubinski,6 Dominic L Jack,8 Frederik Barkhof9. ▸ Additional material is published online only. To view please visit the journal online. (http://dx.doi.org jnnp ). 1Department of Neurological &. Behavioral Sciences, University of Siena, Siena, Italy. 2Department of ...
Journal of the Neurological Sciences
www.infona.pl
Nicola De Stefano, Maria Pia Sormani, Bettina Stubinski, Gregg Blevins, more · Journal of the Neurological Sciences > > 312 > 1-2 > The IMPROVE study demonstrated that the fetal bovine serum (FBS)- and human serum albumin (HSA)-free formulation of subcutaneous (sc) interferon ...
Oral Cladribrine Treatment Reduces Brain Atrophy Rates in...
n.neurology.org
Oral Cladribrine Treatment Reduces Brain Atrophy Rates in Relapsing-Remitting Multiple Sclerosis: Exploratory Analysis of the CLARITY Study (P ). Nicola De Stefano, Antonio Giorgio, Alessandro De Leucio, Anthony Hamlett, Matthew Scaramozza and Bettina Stubinski. First published February 8, 2016,. Nicola De ...
msspeaks :: (Abstract) REGARD study (compares Rebif & Copaxone)
msspeaks.easyphpbb.com
Daniel D Mikol MD a , Frederik Barkhof MD b, Peter Chang PhD c, Patricia K Coyle MD d, Douglas R Jeffery MD e, Steven R Schwid MD f, Bettina Stubinski MD g and Bernard MJ Uitdehaag MD b, on behalf of the REGARD study group *Members listed at end of paper Affiliates of Merck KGaA, Darmstadt, ...
Related search requests for Bettina Stubinski
| Thomas Meyer Ludwig Kappos Ingrid Rohner |
People Forename "Bettina" (7590) Name "Stubinski" (2) |
sorted by relevance / date